State Street Corp Ionis Pharmaceuticals Inc Call Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IONS
# of Institutions
392Shares Held
124MCall Options Held
2.22MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA13.8MShares$523 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$477 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$390 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$312 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$248 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.36B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...